Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
AZD2820
AstraZeneca halts development of anti-obesity drug
AstraZeneca halts development of anti-obesity drug
Marketwatch
AstraZeneca
AZD2820
obesity
Palatin
AZ halts obesity drug trial, completes Ardea purchase
AZ halts obesity drug trial, completes Ardea purchase
Pharma Times, UK
Ardea Biosciences
AstraZeneca
AZD2820
M&A
obesity
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT